Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Safety, Efficacy and Pharmacokinetic Evaluation Study of Intralesional Ronkyla Plus Injection for the Treatment of Superficial Lipoma

NCT07237425 is registered in ClinicalTrials.gov with Glonova Pharma Co., Ltd as lead sponsor.

NCT NCT07237425
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07237425 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Safety, Efficacy and Pharmacokinetic Evaluation Study of Intralesional Ronkyla Plus Injection for the Treatment of Superficial Lipoma
Lead sponsor
Glonova Pharma Co., Ltd
Phase
Phase 1
Overall status
Recruiting
Start date
November 14, 2025
Completion date
August 31, 2028
Enrollment
56 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

lipoma, submental fullness